NCT00252148View on ClinicalTrials.gov

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
HIV Infection
Interventions
BIOLOGICAL

ADMVA

experimental HIV vaccine, MVA vector expressing HIV clade C env, gag, pol, nef, and tat

Trial Locations (2)

10021

Rockefeller University Hospital, New York

14642

University of Rochester Medical Center, Rochester

Sponsors
All Listed Sponsors
collaborator

Aaron Diamond AIDS Research Center

OTHER

collaborator

University of Rochester

OTHER

lead

International AIDS Vaccine Initiative

NETWORK